SCHEMBL21046138

SCHEMBL21046138

N#Cc1ccc(-c2c(-c3ccccc3)c(N3c4ccccc4C(c4ccccc4)(c4ccccc4)c4ccccc43)nc(N3c4ccccc4C(c4ccccc4)(c4ccccc4)c4ccccc43)c2N2c3ccccc3C(c3ccccc3)(c3ccccc3)c3ccccc32)cc1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
AR P10275 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
SLC22A12 Q96S37 1/20 0.31
ABCB1 P08183 2/20 0.30
ABCG2 Q9UNQ0 2/20 0.30
MAPK13 O15264 1/20 0.30
RAF1 P04049 1/20 0.30
MAPK12 P53778 1/20 0.30
MAPK11 Q15759 1/20 0.30
MAPK14 Q16539 1/20 0.30
MYC P01106 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21046112 0.89 MAPK13 (0.33) ALDH1A3MEN1KMT2AATMAR
SCHEMBL21046131 0.87 AR (0.35) ALDH1A3MEN1KMT2AATMAR
SCHEMBL22457909 0.80 PGR (0.38) ALDH1A3MEN1KMT2AATMAR
SCHEMBL21085446 0.76 PDK2 (0.36) ALDH1A3MEN1KMT2AATMGABRA1
SCHEMBL22457902 0.76 MEN1 (0.40) ALDH1A3MEN1KMT2AATMAR
SCHEMBL19345024 0.76 PGR (0.42) ALDH1A3MEN1KMT2AATMAR
SCHEMBL20769874 0.75 MYC (0.38) ALDH1A3MEN1KMT2AATMAR
SCHEMBL22457903 0.75 MEN1 (0.34) ALDH1A3MEN1KMT2AATMAR
SCHEMBL13143195 0.74 PGR (0.41) ALDH1A3ARGABRA1GABRG2GABRB3
SCHEMBL13143204 0.74 PGR (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11849634-B2 Composition of matter for use in organic light- emitting diodes KYULUX, INC. (JP) 2023-12-19 US disclosed
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 US disclosed
CN-111051471-A Composition for use in organic light emitting diodes 九州有机光材股份有限公司 2020-04-21 CN disclosed
US-20190173017-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190173017-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, ALDH1A2, CYBA ALDH1A3 29/4885MEN1 2756/4885KMT2A 4204/4885
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 ALDH1A3 35/4885MEN1 2193/4885KMT2A 4367/4885
US-11849634-B2 Composition of matter for use in organic light- emitting diodes NDUFV3, NDUFV2, CRY2 ALDH1A3 35/4885MEN1 2193/4885KMT2A 4367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.